[Anosmia secondary to acute rhinitis: clinical signs and course in a series of 118 patients].
We report here a series of 118 patients (79% women) who developed dysomia after acute rhinitis. Mean age was 59 years. Mean follow-up after the initial rhinal episode was 36 months. The dominant olfactory disorder was anosmia (71% of the patients) and dysgeusia in 71%. The prognosis of anosmia was poor as it persisted in 50% of the patients. Six patients (5%) recovered normal olfaction after a delay of 11 months. Partial recovery was observed in 45% of the patients with a mean 14-month delay. Recovery of olfaction was thus observed within the first year. Parosmia was also frequent (59% of the patients). In two out of three cases, parosmia persisted. Improvement generally occurred during the first 18 months. These olfactory disorders have an impact on the patients' psychic equilibrim since a depressive syndrome was observed in 60% of the cases.
Faulcon
P
P
Service d'ORL et de Chirurgie Cervico-Faciale, Hôpital Boucicaut, Paris, France.
Portier
F
F
Biacabe
B
B
Bonfils
P
P
D000208:Acute Disease; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D003865:Major Depressive Disorder / Q000209:etiology; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000857:Olfaction Disorders / Q000188:drug therapy / Q000209:etiology* / Q000523:psychology; D011446:Prospective Studies; D012220:Rhinitis / Q000150:complications*; D012720:Severity of Illness Index; D013997:Time Factors; D014803:Vitamin B Complex / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D014803:Vitamin B Complex; D015032:Zinc